When it comes to managing stakeholders, few can outshine Silviu Itescu. His company, Mesoblast, listed on the Australian Securities Excha…
When it comes to managing stakeholders, few can outshine Silviu Itescu. His company, Mesoblast, listed on the Australian Securities Excha…
The founder and chief executive of drug therapy company Mesoblast has seen the value of his stake in the company leap from $72.4 million to …
